Phenotype-based approach to obesity treatment shows promise

The FDA hit Amazon with a warning letter on December 20 for distributing energy supplements for men that contain potentially harmful pharmaceutical ingredients. These products,

Roche is ac­quir­ing its cell ther­a­py and ge­nom­ic med­i­cines part­ner Po­sei­da Ther­a­peu­tics, the com­pa­nies said Tues­day morn­ing. The Basel-based phar­ma gi­ant … Sign up to